Germinal centers are permissive to subdominant antibody responses.

agent-based model (ABM) antibodies germinal center (GC) immunodominance (ID) vaccine model

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 10 06 2023
accepted: 13 12 2023
medline: 29 1 2024
pubmed: 26 1 2024
entrez: 26 1 2024
Statut: epublish

Résumé

A protective humoral response to pathogens requires the development of high affinity antibodies in germinal centers (GC). The combination of antigens available during immunization has a strong impact on the strength and breadth of the antibody response. Antigens can display various levels of immunogenicity, and a hierarchy of immunodominance arises when the GC response to an antigen dampens the response to other antigens. Immunodominance is a challenge for the development of vaccines to mutating viruses, and for the development of broadly neutralizing antibodies. The extent by which antigens with different levels of immunogenicity compete for the induction of high affinity antibodies and therefore contribute to immunodominance is not known. Here, we perform We found that GC dynamics were driven by the most immunogenic domain and immunodominance arose as affinity maturation to less immunogenic domain was inhibited. However, this inhibition was moderate since the less immunogenic domain exhibited a weak GC response in the absence of the most immunogenic domain. Less immunogenic domains reduced the dominance of GC responses to more immunogenic domains, albeit at a later time point. The simulations suggest that increased vaccine valency may decrease immunodominance of the GC response to strongly immunogenic domains and therefore, act as a potential strategy for the natural induction of broadly neutralizing antibodies in GC reactions.

Identifiants

pubmed: 38274834
doi: 10.3389/fimmu.2023.1238046
pmc: PMC10808553
doi:

Substances chimiques

Broadly Neutralizing Antibodies 0
Antigens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1238046

Informations de copyright

Copyright © 2024 Robert, Arulraj and Meyer-Hermann.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cell. 2016 Sep 8;166(6):1471-1484.e18
pubmed: 27610571
J Mol Biol. 1996 Mar 1;256(3):623-44
pubmed: 8604144
iScience. 2021 Jul 17;24(8):102861
pubmed: 34401660
Annu Rev Immunol. 2022 Apr 26;40:413-442
pubmed: 35113731
Nat Commun. 2018 Sep 25;9(1):3903
pubmed: 30254319
Philos Trans R Soc Lond B Biol Sci. 2015 Sep 5;370(1676):
pubmed: 26194759
Cell. 2015 Feb 12;160(4):785-797
pubmed: 25662010
iScience. 2021 Aug 14;24(9):102979
pubmed: 34485861
Immunity. 2007 Aug;27(2):190-202
pubmed: 17723214
Cell Syst. 2020 Dec 16;11(6):573-588.e9
pubmed: 33031741
PLoS Pathog. 2016 Jun 28;12(6):e1005702
pubmed: 27351973
Immunity. 2018 Jan 16;48(1):133-146.e6
pubmed: 29287996
Cell Rep. 2017 Feb 28;18(9):2175-2188
pubmed: 28249163
Immunity. 2016 Mar 15;44(3):542-552
pubmed: 26948373
Cell. 2016 Sep 8;166(6):1445-1458.e12
pubmed: 27610569
Science. 2016 Mar 4;351(6277):1048-54
pubmed: 26912368
Nat Comput Sci. 2022 Dec;2(12):845-865
pubmed: 38177393
Nat Immunol. 2023 Jul;24(7):1124-1137
pubmed: 37217705
Lancet Infect Dis. 2016 Aug;16(8):942-51
pubmed: 27061888
Science. 2015 Aug 7;349(6248):643-6
pubmed: 26184917
Cell Rep. 2012 Jul 26;2(1):162-74
pubmed: 22840406
Am J Respir Crit Care Med. 2011 Mar 15;183(6):767-73
pubmed: 20935106
Front Immunol. 2018 Oct 25;9:2469
pubmed: 30410492
Nat Rev Immunol. 2023 Mar;23(3):142-158
pubmed: 35962033
Science. 2018 Apr 13;360(6385):223-226
pubmed: 29650674
J Exp Med. 2013 Mar 11;210(3):457-64
pubmed: 23420879
J Exp Med. 2023 Feb 6;220(2):
pubmed: 36512034
Immunol Rev. 2012 May;247(1):52-63
pubmed: 22500831
Vaccine. 2023 Feb 24;41(9):1589-1601
pubmed: 36732163
Nature. 2021 Aug;596(7870):109-113
pubmed: 34182569
Nat Commun. 2018 Apr 11;9(1):1386
pubmed: 29643370
Adv Bioinformatics. 2012;2012:148045
pubmed: 22934109
J Virol. 2016 Apr 14;90(9):4720-4734
pubmed: 26912624
PLoS Comput Biol. 2017 Jan 30;13(1):e1005336
pubmed: 28135270
Cell. 2020 Jan 9;180(1):92-106.e11
pubmed: 31866068
Cell. 2014 Jul 31;158(3):481-91
pubmed: 25065977
Immunol Rev. 2016 May;271(1):230-45
pubmed: 27088918
Cell Rep. 2019 Oct 29;29(5):1066-1073.e5
pubmed: 31665624
Immunol Rev. 2016 Mar;270(1):8-19
pubmed: 26864101
J Exp Med. 2018 Jan 2;215(1):77-90
pubmed: 29247044
Cell Rep. 2021 Oct 12;37(2):109823
pubmed: 34610291
Immunol Rev. 2018 Jul;284(1):42-50
pubmed: 29944756
iScience. 2020 Sep 17;23(10):101568
pubmed: 33083735
Nat Microbiol. 2022 Aug;7(8):1180-1188
pubmed: 35836002
J Virol. 2020 Feb 28;94(6):
pubmed: 31826999
Cell Rep. 2021 Aug 24;36(8):109552
pubmed: 34433043
Cell Host Microbe. 2020 Oct 7;28(4):572-585.e7
pubmed: 32697938
Toxicol Appl Pharmacol. 2016 May 15;299:70-7
pubmed: 26773813
Immunity. 2023 Sep 12;56(9):2137-2151.e7
pubmed: 37543032
Curr Opin Biotechnol. 2018 Jun;51:137-145
pubmed: 29414440
Nature. 2013 Apr 25;496(7446):469-76
pubmed: 23552890
Immunity. 2013 Mar 21;38(3):596-605
pubmed: 23499493
Infect Immun. 1999 Mar;67(3):1303-9
pubmed: 10024575
Front Immunol. 2023 Mar 13;14:1080853
pubmed: 36993964

Auteurs

Philippe A Robert (PA)

Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Department of Biomedicine, University of Basel, Basel, Switzerland.

Theinmozhi Arulraj (T)

Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Michael Meyer-Hermann (M)

Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Institute for Biochemistry, Biotechnology and Bioinformatics, Technische Universität Braunschweig, Braunschweig, Germany.

Articles similaires

Animals Humans TOR Serine-Threonine Kinases Lupus Erythematosus, Systemic Arthritis, Rheumatoid
Humans Malaria, Vivax Plasmodium vivax Antibodies, Protozoan Adult
Humans Pregnancy Female Developing Countries Prenatal Care
Humans Bangladesh Infant Female Male

Classifications MeSH